These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 28281460

  • 1. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody.
    De Souza FHC, Miossi R, Shinjo SK.
    Clin Exp Rheumatol; 2017; 35(5):766-771. PubMed ID: 28281460
    [Abstract] [Full Text] [Related]

  • 2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [Abstract] [Full Text] [Related]

  • 3. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J.
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
    Suzuki S, Nishikawa A, Kuwana M, Nishimura H, Watanabe Y, Nakahara J, Hayashi YK, Suzuki N, Nishino I.
    Orphanet J Rare Dis; 2015 May 13; 10():61. PubMed ID: 25963141
    [Abstract] [Full Text] [Related]

  • 6. Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
    Miller T, Al-Lozi MT, Lopate G, Pestronk A.
    J Neurol Neurosurg Psychiatry; 2002 Oct 13; 73(4):420-8. PubMed ID: 12235311
    [Abstract] [Full Text] [Related]

  • 7. Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
    Ashton C, Junckerstorff R, Bundell C, Hollingsworth P, Needham M.
    Neuromuscul Disord; 2016 Nov 13; 26(11):734-740. PubMed ID: 27665513
    [Abstract] [Full Text] [Related]

  • 8. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
    Wang L, Liu L, Hao H, Gao F, Liu X, Wang Z, Zhang W, Lv H, Yuan Y.
    Neuromuscul Disord; 2014 Apr 13; 24(4):335-41. PubMed ID: 24491486
    [Abstract] [Full Text] [Related]

  • 9. Immune-mediated necrotising myopathy in asymptomatic patients with high creatine kinase.
    Soares IFZ, Comprido VF, Hsu BRRHS, Alves de Siqueira Carvalho A.
    BMJ Case Rep; 2020 Oct 08; 13(10):. PubMed ID: 33033004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
    Carvalho AAS, Silva VGD, Vieira TF, Delgado PO, Corazini R, Feder D, Fonseca FLA.
    Medicine (Baltimore); 2018 Aug 08; 97(35):e11858. PubMed ID: 30170376
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
    Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O.
    Arthritis Rheum; 2011 Jul 08; 63(7):1961-71. PubMed ID: 21400483
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
    Picard C, Vincent T, Lega JC, Hue S, Fortenfant F, Lakomy D, Humbel RL, Goetz J, Molinari N, Bardin N, Bertin D, Johanet C, Chretien P, Dubucquoi S, Streichenberger N, Desplat-Jégo S, Bossuyt X, Sibilia J, Abreu I, Chevailler A, Fabien N.
    Immunol Res; 2016 Jun 08; 64(3):677-86. PubMed ID: 26744256
    [Abstract] [Full Text] [Related]

  • 16. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R, Moghadam-Kia S, Lacomis D, Malik A, Qi Z, Koontz D, Burlingame RW, Oddis CV.
    Scand J Rheumatol; 2020 Sep 08; 49(5):405-411. PubMed ID: 31801390
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
    Nóvoa Medina FJ, Gutiérrez Martínez J, González González Y, Romero Díaz B, Machín García S, Rosas Romero A.
    Reumatol Clin (Engl Ed); 2018 Sep 08; 14(6):379-381. PubMed ID: 28389200
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
    Cui BB, Tian YR, Ma XY, Yin G, Xie Q.
    Front Immunol; 2021 Sep 08; 12():777502. PubMed ID: 34925350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.